PUT - SPRINTER OPEN END - DEXCOM Share Price

DE000VD1ZAK3

Real-time Boerse Frankfurt Warrants 11:34:38 16/05/2024 pm IST
2.91 ^EUR	-3.64%

Current month	-9.06%
1 month	+21.76%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

DexCom : Human Rights Statement	09/05	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	30/04	CI
Wall Street: the worst week of 2024 is followed by the best	27/04	CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122	26/04	MT

More news

Quotes 5-day view

Date	Price	Change
16/24/16	2.91	-3.64%
15/24/15	3.02	-12.72%
14/24/14	3.46	+1.47%
13/24/13	3.41	+4.28%
10/24/10	3.27	+5.83%

Real-time Boerse Frankfurt Warrants

Last update May 16, 2024 at 11:34 pm IST

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	PUT
Underlying	DEXCOM, INC.
Issuer	Vontobel
WKN	VD1ZAK
ISIN	DE000VD1ZAK3
Date issued	11/03/2024
Strike	162 $
Maturity	Unlimited
Parity	10 : 1
Emission price	2.52 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	3.54 €
Lowest since issue	1.8 €
Spread	0.08 €
Spread %	2.81%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

131.9 USD

Average target price

151.2 USD

Spread / Average Target

+14.64%

Consensus